The Latest Strategies To Reduce Cardiac Device Infections
Tuesday 29th October 2019
@ 17:00 (GMT)
Reserve Your Seat for this event.
Prof Christian Butter (Moderator)
Dr Mauro Biffi (Presenter)
Dr Jay Wright (Presenter)
Infection of Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers, ICDs and CRT devices has a high impact on a patient’s quality of life, morbidity and mortality. In addition, it is a costly burden to healthcare. New solutions are available to reduce these CIED infections; these solutions, the latest evidence and its impact on clinical practice will be presented and discussed in this webinar.
Prof Christian Butter is Chief of Cardiology at the Heart Center Brandenburg in Bernau/Berlin, Germany. He has a special interest in research and innovation and has pioneered several new technologies in cardiology.
Dr Mauro Biffi is Clinical Cardiologist, Director of Electrophysiology at the Hospital San Orsola and tutor at the Cardiology School of Bologna University, Italy. He has participated in several international clinical studies and his main areas of interest are arrhythmias, heart failure and device therapy of brady and tachy-arrhythmias.
Dr Jay Wright is Consultant Cardiologist, at the Liverpool Heart and Chest Hospital and he is a senior lecturer at Liverpool University and Imperial College London, United Kingdom. He is a committee member for NICOR devices survey and a council member of the British Cardio-Oncology Society (BC-OS).
This webinar aims to inform cardiologists, cardiac device implanters and allied healthcare professionals who are involved in the implantation of patients with pacemakers, ICDs and CRTs on:
- The impact of CIED infections on the patient, the hospital and on the associated costs.
- The latest clinical evidence supporting the use of an antibacterial envelope in preventing device infections.
- How the clinical evidence can be implemented in clinical practice.
- Cardiologists and allied healthcare professionals involved in CIED implantation.
- Henrikson CA. Antibacterial Envelope Is Associated with Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. JACC Clin Electrophysiol 2017; 3(10):1158-1167.
- Tarakji KG. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med 2019; 380(20):1895-1905.
